Antiretroviral (ARV) drug interactions in HIV-infected liver transplant (LTx) recipients can lead to increased levels of immunosuppressive agents (Is) which are responsible to induce acute renal failure and other major toxicities.
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation / Guaraldi, Giovanni; Cocchi, S.; Ciaffi, S.; Motta, A.; Pinetti, D.; Codeluppi, M.; Bonora, S.; DI BENEDETTO, Fabrizio; Masetti, M.; Di Sandro, S.; Nardini, Giulia; Bertolini, A.; Gerunda, Giorgio Enrico; Esposito, Roberto. - STAMPA. - # P4.2/04:(2007), pp. not available-not available. (Intervento presentato al convegno EACS tenutosi a Madrid, Spain nel 24-27 October 2007).
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation
GUARALDI, Giovanni;DI BENEDETTO, Fabrizio;Di Sandro S.;NARDINI, Giulia;GERUNDA, Giorgio Enrico;ESPOSITO, Roberto
2007
Abstract
Antiretroviral (ARV) drug interactions in HIV-infected liver transplant (LTx) recipients can lead to increased levels of immunosuppressive agents (Is) which are responsible to induce acute renal failure and other major toxicities.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
